Evidence map›Paper›PMID 31059046›Full record

ArticleMolecular medicine reports2019

Inhibitory effect of 17β‑estradiol on triglyceride synthesis in skeletal muscle cells is dependent on ESR1 and not ESR2.

Quan Liu, Rui Li, Guanjun Chen, Jianming Wang, Bingfeng Hu, Chaofei Li, Xiaohuan Zhu, Yunxia Lu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The role ofArchives animal breeding · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Quan LiuDepartment of Clinical Pharmacy, Class 2014, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Rui LiDepartment of Clinical Pharmacy, Class 2014, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Guanjun ChenCenter of Scientific Research, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Jianming WangDalian Maple International School, Dalian, Liaoning 116100, P.R. China.
Bingfeng HuDepartment of Clinical Pharmacy, Class 2014, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Chaofei LiThe Comprehensive Laboratory, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Xiaohuan ZhuDepartment of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Yunxia LuThe Comprehensive Laboratory, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNLiaoning University of International Business and Economics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the inhibitory effects and the mechanisms underlying 17β‑estradiol (E2) effects on triglyceride synthesis and insulin resistance in skeletal muscle tissues and cells. Ovariectomy (OVX) was performed on 6‑month‑old female rats treated with or without E2. Subsequently, various serum biochemical markers were measured. Additionally, pathological alterations of the uterus, liver and skeletal muscle were analyzed, and the content of triglycerides (TG) in muscle was detected. Differentiated myotubes formed by C2C12 cells were treated with palmitic acid (PA) or pretreated with E2, estrogen receptor (ESR) 1 agonist propylpyrazoletriol (PPT) and ESR2 agonist diarylpropionitrile (DPN). Subsequently, the mRNA or protein expression levels of ESR1/2, peroxisome proliferator activated receptor α (PPARα), CD36 molecule (CD36), fatty acid synthase (FASN), perilipin 2 (PLIN2), phosphorylated acetyl‑CoA carboxylase α (p‑ACACA), p‑AKT serine/threonine kinase (p‑AKT) and p‑mitogen‑activated protein kinase 8 (p‑MAPK8) were analyzed in skeletal muscle or in C2C12 cells by reverse transcription‑semi‑quantitative polymerase chain reaction and western blotting. The present results suggested that treatment with E2 inhibited OVX‑induced body weight gain, TG accumulation and insulin resistance. The protein or mRNA expression levels of ESR1, CD36, PPARα, p‑ACACA and p‑AKT were decreased, whereas the protein or mRNA expression levels of ESR2, PLIN2, FASN and p‑MAPK8 were increased in the OVX group. Of note, treatment with E2 restored the expression levels of the aforementioned factors. In C2C12 cells, treatment with E2 or PPT reversed the alterations induced by treatment with PA. In contrast, pretreatment with DPN did not influence the effect of PA. Collectively, E2 was able to interact with ESR1, thus activating the CD36‑PPARα pathway, decreasing the level of TG in the muscles and improving insulin resistance in skeletal muscles and C2C12 cells.

Indexed as

AnimalsCell LineDown-RegulationEstradiolEstrogen Receptor alphaEstrogen Receptor betaFatty Acid SynthasesFemaleInsulin ResistanceMiceMuscle, SkeletalOvariectomyPalmitic AcidPerilipin-2PhenolsProto-Oncogene Proteins c-akt4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenolEstradiolEstrogen Receptor alphaEstrogen Receptor betaFatty Acid SynthasesPalmitic AcidPerilipin-2PhenolsProto-Oncogene Proteins c-aktPyrazolesTriglycerides

Identifiers

PMID31059046
PMCPMC6522926
OpenAlexW2940512194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.